comparemela.com

Latest Breaking News On - Gaurav shah - Page 1 : comparemela.com

Avoro Capital Advisors LLC Increases Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Avoro Capital Advisors LLC increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,260,900 shares of the biotechnology company’s stock after buying an additional 10,900 shares during the quarter. […]

New-york
United-states
William-blair
Gaurav-shah
John-militello
News-ratings-for-rocket-pharmaceuticals-daily
Avoro-capital-advisors
Principal-financial-group-inc
Nasdaq
Rocket-pharmaceuticals
Rocket-pharmaceuticals-inc
Jpmorgan-chase-co

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Kinnari-patel
Gaurav-shah
Rocket-pharmaceuticals-trading-down
Nasdaq
Earnings-history-for-rocket-pharmaceuticals
Needham-company
Securities-exchange-commission
Rocket-pharmaceuticals
Goldman-sachs-group
Jpmorgan-chase-co
News-ratings-for-rocket-pharmaceuticals-daily
Rocket-pharmaceuticals-inc

Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress

Advanced RP-L102 for Fanconi Anemia towards regulatory reviews; EMA accepted MAA for review and BLA submission anticipated in the first half of 2024 Continued preparations to launch LV portfolio.

California
United-states
Stanford-university
American
America
Los-angeles
Agnieszka-czechowicz
Donaldb-kohn
Gaurav-shah
Company-cranbury
Dodge
Stanford-university-school-of-medicine

China Universal Asset Management Co. Ltd. Buys 8,356 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

China Universal Asset Management Co. Ltd. lifted its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 404.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,424 shares of the biotechnology company’s stock after buying an additional 8,356 shares during the […]

China
Gaurav-shah
Gotham-makker
Rocket-pharmaceuticals-price-performance
Annandale-capital
Goldman-sachs-group
Nasdaq
Jpmorgan-chase-co
China-universal-asset-management-co
Wells-fargo-company
Steward-partners-investment-advisory
Rocket-pharmaceuticals-company-profile

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Gotham-makker
Gaurav-shah
Jpmorgan-chase-co
Rocket-pharmaceuticals-stock-performance
Rocket-pharmaceuticals-company-profile
Cantor-fitzgerald
Nasdaq
Rocket-pharmaceuticals
Institutional-investors-weigh-in-on-rocket-pharmaceuticals
News-ratings-for-rocket-pharmaceuticals-daily
Goldman-sachs-group
Rocket-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.